Digitalization for Pharmaceuticals: Safeguarding Product Supply by Ensuring Asset and Process Health
In the pharmaceutical industry, equipment failures, changing operating conditions and other unexpected occurrences can cause batch failures, resulting in costly production losses and disruptions to supply. So how can companies maintain the security of supply while protecting profits?
In this white paper, read examples of how pharmaceutical companies are turning to asset performance management to help them:- Predict equipment breakdowns weeks in advance, allowing staff time to schedule maintenance and prevent production losses
- Ensure process consistency and drive greater product quality and yield
- Reduce CAPEX and extend the life of critical assets
Learn how advanced analytics technology, including predictive maintenance and multivariate analytics, are helping pharmaceutical companies achieve a competitive advantage.
Related Content
.jpg?sc_lang=en&h=205&w=400&la=ja&hash=63EA06878ED3DA88A87D76DCF41C239E)
Where are you in your digitalization journey? Given recent market volatility, many companies are benefiting from early adoption of digital technologies. Innovations like AI and data analytics improve response times and help keep assets running safely and more cost-effectively. Join industry leaders GSK and Wood as they detail progress with their digital strategies including insight into deployment across multiple sites around the world. Hear about their challenges and successes in bringing extended transparency to operations to improve decision making, adapt quickly to new demands and maximize uptime.